DK447688D0 - Fremgangsmaade til isolering af basiske proteiner fra proteinblandinger - Google Patents

Fremgangsmaade til isolering af basiske proteiner fra proteinblandinger

Info

Publication number
DK447688D0
DK447688D0 DK447688A DK447688A DK447688D0 DK 447688 D0 DK447688 D0 DK 447688D0 DK 447688 A DK447688 A DK 447688A DK 447688 A DK447688 A DK 447688A DK 447688 D0 DK447688 D0 DK 447688D0
Authority
DK
Denmark
Prior art keywords
basic proteins
procedure
protein ingredients
insulating basic
insulating
Prior art date
Application number
DK447688A
Other languages
English (en)
Other versions
DK447688A (da
DK173502B1 (da
Inventor
Michael Doerschug
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK447688D0 publication Critical patent/DK447688D0/da
Publication of DK447688A publication Critical patent/DK447688A/da
Application granted granted Critical
Publication of DK173502B1 publication Critical patent/DK173502B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198804476A 1987-08-11 1988-08-10 Fremgangsmåde til isolering af insulinderivater med basisk karakter fra proetinblandinger DK173502B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3726655 1987-08-11
DE19873726655 DE3726655A1 (de) 1987-08-11 1987-08-11 Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten

Publications (3)

Publication Number Publication Date
DK447688D0 true DK447688D0 (da) 1988-08-10
DK447688A DK447688A (da) 1989-02-12
DK173502B1 DK173502B1 (da) 2001-01-08

Family

ID=6333496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804476A DK173502B1 (da) 1987-08-11 1988-08-10 Fremgangsmåde til isolering af insulinderivater med basisk karakter fra proetinblandinger

Country Status (19)

Country Link
US (1) US5101013A (da)
EP (1) EP0305760B1 (da)
JP (1) JP2587867B2 (da)
KR (1) KR0129539B1 (da)
AT (1) ATE96447T1 (da)
AU (1) AU609170B2 (da)
CA (1) CA1340237C (da)
DE (2) DE3726655A1 (da)
DK (1) DK173502B1 (da)
ES (1) ES2047007T3 (da)
FI (1) FI91875C (da)
HU (1) HU198218B (da)
IE (1) IE61557B1 (da)
IL (1) IL87385A (da)
NO (1) NO175004C (da)
NZ (1) NZ225746A (da)
PH (1) PH26874A (da)
PT (1) PT88230B (da)
ZA (1) ZA885871B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG46612A1 (en) 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
DE59711533D1 (de) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
DE19652713C2 (de) * 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
KR100341297B1 (ko) * 1997-03-29 2002-11-16 주식회사종근당 재조합활성형프로인슐린의분리.정제방법
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
US6444788B1 (en) * 1999-03-15 2002-09-03 Novo Nordisk A/S Ion exchange chromatography of GLP-1, analogs and derivatives thereof
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
ATE509028T1 (de) * 1999-03-15 2011-05-15 Novo Nordisk As Ionen-austausch-chromatographische trennung von glp-1 und verwandten peptiden
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
SE0300791D0 (sv) * 2003-03-20 2003-03-20 Amersham Biosciences Ab Use of ph-responsive polymers
BRPI0413644A (pt) * 2003-08-21 2006-10-17 Novo Nordisk As métodos para separar as duas formas de um polipeptìdeo tendo uma única racemização de aminoácido, e para separar dois polipeptìdeos, produto de polipeptìdeo, e, composição farmacêutica
CN101282880B (zh) * 2005-08-04 2012-12-05 东洋制罐株式会社 塑料瓶灭菌方法
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
FR2947818B1 (fr) * 2009-07-09 2011-07-29 Inst Superieur Des Sciences Agronomiques Agroalimentaires Horticoles Et Du Paysage Agro Campus Ouest Utilisation d'un coproduit issu d'un procede d'extraction du lysozyme a partir de blanc d'oeuf, pour l'obtention d'au moins une proteine basique de blanc d'oeuf
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
DK2498802T3 (da) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Farmaceutisk præparat omfattende en glp-1-agonist, et insulin og en methionin
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
DK2748181T3 (da) * 2011-09-30 2016-05-23 Ge Healthcare Bioprocess R&D Ab Fremgangsmåde til oprensning af spaltet pro-insulin
US10421795B2 (en) * 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
WO2015138548A1 (en) 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3581578A4 (en) * 2017-02-10 2020-04-22 Mitsubishi Chemical Corporation Separating agent for human insulin purification and human insulin purification method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2629568C3 (de) * 1976-07-01 1981-09-10 Hoechst Ag, 6000 Frankfurt Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten
NL7713966A (nl) * 1976-12-27 1978-06-29 Univ Minnesota Werkwijze voor het behandelen van insuline.
DK311477A (da) * 1977-07-08 1979-01-09 Leo Lab Fremgangsmaade ved fremstilling af rent insulin
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
DE3486216T2 (de) * 1983-04-25 1994-02-17 Chiron Corp Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.
DE3440988A1 (de) * 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
DE3511269A1 (de) * 1985-04-12 1986-10-09 Veb Berlin-Chemie, Ddr 1199 Berlin Verfahren zur reinigung von insulin
JPS6379591A (ja) * 1986-09-22 1988-04-09 Mitsui Toatsu Chem Inc ｔＰＡの精製方法
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
ES2064412T3 (es) * 1988-10-26 1995-02-01 American Cyanamid Co Procedimiento para reducir el contenido de aglomerado de materiales tipo hormona del crecimiento.

Also Published As

Publication number Publication date
FI883708A0 (fi) 1988-08-09
AU2059188A (en) 1989-02-16
PH26874A (en) 1992-11-16
FI883708L (fi) 1989-02-12
DE3726655A1 (de) 1989-02-23
EP0305760A2 (de) 1989-03-08
IL87385A0 (en) 1989-01-31
EP0305760A3 (en) 1990-06-06
NO175004C (no) 1994-08-17
NO883554L (no) 1989-02-13
ZA885871B (en) 1989-04-26
NO883554D0 (no) 1988-08-10
EP0305760B1 (de) 1993-10-27
NZ225746A (en) 1990-11-27
AU609170B2 (en) 1991-04-26
HU198218B (en) 1989-08-28
DE3885214D1 (de) 1993-12-02
US5101013A (en) 1992-03-31
PT88230B (pt) 1995-03-01
FI91875B (fi) 1994-05-13
KR0129539B1 (ko) 1998-04-04
JP2587867B2 (ja) 1997-03-05
KR890003799A (ko) 1989-04-18
IL87385A (en) 1993-08-18
CA1340237C (en) 1998-12-15
JPS6486896A (en) 1989-03-31
PT88230A (pt) 1989-06-30
HUT47958A (en) 1989-04-28
ES2047007T3 (es) 1994-02-16
IE882441L (en) 1989-02-11
FI91875C (fi) 1994-08-25
IE61557B1 (en) 1994-11-16
NO175004B (no) 1994-05-09
DK447688A (da) 1989-02-12
DK173502B1 (da) 2001-01-08
ATE96447T1 (de) 1993-11-15

Similar Documents

Publication Publication Date Title
DK447688A (da) Fremgangsmaade til isolering af basiske proteiner fra proteinblandinger
NO20076467L (no) Fusjonsproteiner som omfatter HIV-1 Tat- og/eller Nef-proteiner
CY1112195T1 (el) Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5
FI844817A0 (fi) Dispergeringsmedel foer salthaltiga system.
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
DK165988C (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
ATE393823T1 (de) Nukleinsäure bindende proteine
DK250181A (da) Fremgangsmaade til fremstilling af vinblastinderivater
MX9203519A (es) Metodo de recombinacion para la produccion de inhibidores de proteasa de serina y secuencias de adn utiles para los mismos.
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
AR016436A1 (es) Proteina que inhibe a la p27, adn que la codifica, anticuerpos y productos de disociacion de los mismos, acido nucleico antisentido, estructura artificialde acido nucleico y la utilizacion de todo esto en terapia y profilaxis de enfermedades
LV10490A (lv) DNS seciba kas kode proteinus ar HUSI-tipa inhibitoru biologisko aktivitati mineto proteinu iegusanas biotehnologiskais panemiens farmaceitiskas kompozicijas kas satur minetos proteinus
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
DK383388A (da) 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling
IE822519L (en) Phosphonic acid derivatives
DK1062244T3 (da) Forbedrede fremgangsmåder til fremstilling af faktor VIII proteiner
DK560686D0 (da) Fremgangsmaade til fremstilling af proteiner ved hjaelp af vaertsorganismer, fortrinsvis maelkesyrebakterier
DK319384D0 (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
ES555393A0 (es) Procedimiento para preparar compuestos dimeros de derivados de aminoacidos.
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
Takeshima et al. Ribosomal proteins of sea urchin eggs. I. Characterization of cytoplasmic ribosomal proteins
Vaughn et al. Phosphorylation heterogeneity of tryptic phosphopeptides of chicken riboflavin-binding protein
ES2095187A1 (es) Proteinas inactivadoras de ribosomas, denominadas alfa-ebulitina, beta-ebilitina, de la planta sambucus ubulus, l., procedimiento para su obtencion y su utilizacion.
ES8701149A1 (es) Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos
ATE54544T1 (de) Natriumarmes, als kochsalzsubstitut geeignetes salzgemisch.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired